Current
- 2023-Present – Associate Editor, Genes and Immunity
- 2023-Present – Section Editor, Journal of Translational Medicine
- 2020-Present – Consulting Editor, Pharmacological Research
- 2019-Present – Editor-in-Chief, Methods in Cell Biology
- 2018-Present – Advisory Editor, Cell Communication and Signaling
- 2017-Present – Inaugural Editorial Board Member, iScience
- 2016-Present – Editor-in-Chief, International Review of Cell and Molecular Biology
- 2016-Present – Founding Editor, Cell Stress
- 2014-Present – Associate Editor, Cell Death and Disease
- 2013-Present – Founding Editor, Microbial Cell
- 2013-Present – Founding Editor-in-Chief, Molecular and Cellular Oncology
- 2012-Present – Founding Editor-in-Chief, OncoImmunology
Past
- 2019-2023 – Associate Editor, Aging
- 2019-2022 – Guest Editor, Frontiers in Oncology
- 2019-2021 – Guest Editor, Methods in Cell Biology
- 2019-2021 – Guest Editor, Cells
- 2018-2020 – Guest Editor, Methods in Enzymology
- 2018-2020 – Guest Editor, Progress in Molecular Biology and Translational Science
- 2018-2020 – Section Editor, Cells
- 2015-2018 – Section Chief Editor, Oncotarget
- 2016-2017 – Guest Editor, Methods in Enzymology
- 2016-2017 – Guest Editor, Circulation Research
- 2013-2015 – Associate Editor, Journal of Cancer Research and Therapeutic Oncology
- 2013-2014 – Guest Editor, Methods in Enzymology
- 2012-2013 – Guest Editor, Methods in Molecular Biology
- 2012-2013 – Guest Editor, Circulation Research
- 2010-2013 – Specialty Chief Editor, Frontiers in Molecular and Cellular Oncology
Reviewing
- Served as expert reviewer on more than 100 scientific articles for peer-reviewed international journals including (in alphabetical order): Apoptosis, Autophagy, Biochem Biophys Res Commun, Biochim Biophys Acta, Cancer Cell, Cancer Res, Cell, Cell Cycle, Cell Death Differ, Cell Rep, Cell Res, Dev Cell, EMBO Mol Med, Genes Dev, Immunity, Int J Cancer, J Biol Chem, J Clin Invest, J Pathol, Microb Cell, Mol Cell, Mol Cell Biol, Nat Chem Biol, Nat Immunol, Nat Rev Chem Biol, Nat Rev Drug Discov, Nat Rev Nephrol, Oncogene, Oncoimmunology, Oncotarget, Sci Transl Med, Trends Cancer
